Skip to content

Clinical trials

Phase 1 Lymphoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1 Country / region: South Korea Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20163
20172
20181
20203
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated7
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ADC Therapeutics S.A.1
BeiGene1
Calithera Biosciences, Inc1
Celgene1
Chong Kun Dang Pharmaceutical1
Curis, Inc.1
Dong-A ST Co., Ltd.1
EMD Serono Research & Development Institute, Inc.1
Eisai Inc.1
ImmuneOncia Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma15
Lymphoma, Non-Hodgkin2
Melanoma2
Multiple Myeloma2
Recurrence2
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Central Nervous System Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.